BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

Gangliosidosis Gm1

Download PDF PDF Version

Image Results

Loading...

Recent Publications on Gangliosidosis Gm1:

Pubmed Logo
Axonal degeneration induced by intraneural injection of Campylobacter jejuni antiserum containing high titer anti-GM1 antibody.
Ganglioside-like structures in CAMPYLOBACTER JEJUNI ( C. JEJUNI)...
6th June, 2008
Department of Pediatrics, The First Affiliated Hospital, Zunyi Medical Neuropediatrics. 2007 Oct;38(5):228-32.
DOI Direct Link
Chemical chaperone therapy for GM1-gangliosidosis.
We have proposed a chemical chaperone therapy for lysosomal diseases,...
23rd April, 2008
International University of Health and Welfare Graduate School, 2600-1 Cell Mol Life Sci. 2008 Feb;65(3):351-3.
DOI Direct Link
ER and oxidative stresses are common mediators of apoptosis in both neurodegenerative and non-neurodegenerative lysosomal storage disorders and are alleviated by chemical chaperones.
It is estimated that more than 40 different lysosomal storage disorders...
13th March, 2008
Section on Developmental Genetics, Heritable Disorders Branch, National Hum Mol Genet. 2008 Feb 15;17(4):469-77. Epub 2007 Nov 7.
DOI Direct Link
Brain proton magnetic resonance spectroscopy and neuromuscular pathology in a patient with GM1 gangliosidosis.
The authors report the clinical, neuroradiologic, and neuromuscular...
8th March, 2008
Department of Molecular and Human Genetics, Baylor College of Medicine, J Child Neurol. 2008 Jan;23(1):73-8.
DOI Direct Link
Enhanced autophagy and mitochondrial aberrations in murine G(M1)-gangliosidosis.
G(M1)-gangliosidosis is an autosomal recessive lysosomal lipid storage...
5th March, 2008
Division of Functional Genomics, Research Center for Bioscience and Biochem Biophys Res Commun. 2008 Mar 14;367(3):616-22. Epub 2008 Jan 9.
DOI Direct Link

View more research publications.

BioNews Results for Gangliosidosis Gm1:

RSS Logo
BioPortfolio Logo
Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies
PharmCast:  May 16 2008 4:13AM Matching: gm1

Gangliosidosis Gm1 Clinical Trials:

Clinical Trials Logo
HSCT for High Risk Inherited Inborn Errors
Adrenoleukodystrophy;   Metachromatic Leukodystrophy;   Globoid Cell Leukodystrophy;   Tay Sachs;   Sandhoff, I-Cell, Sanfillipo, GM1 Gangliosidosis

BioPortfolio Ltd. offers e-mail and postal lists for Gangliosidosis Gm1 scientists - we have details of around 23 individuals working on Gangliosidosis Gm1 .


This page has been viewed 88 times
Recent Search Terms used to find this page: gm1 gangliosidosis | gm1 gangliosidosis | clinical trial GM1 gangliosidosis | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Gangliosidosis Gm1 across BioPortfolio, or bestselling Gangliosidosis Gm1 books or recently published Gangliosidosis Gm1 books .
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional